Therapy-Related Acute Myeloid Leukemia Following TCHP Chemotherapy in Two HER2+ Breast Cancer Patients

Increased risk for the development of therapy-induced myeloid leukemia following the treatment of breast cancer has typically been associated with the use of regimens containing anthracyclines or alkylating agents. We present two cases of estrogen receptor-positive/progesterone receptor-positive/hum...

Descripción completa

Detalles Bibliográficos
Autores principales: Gill, Navroop, Chandran, Anjana, Adley, Brian, Bitran, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785496/
https://www.ncbi.nlm.nih.gov/pubmed/33425535
http://dx.doi.org/10.7759/cureus.11957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785496/
https://www.ncbi.nlm.nih.gov/pubmed/33425535
http://dx.doi.org/10.7759/cureus.11957

Ejemplares similares